Pharmacy Daily | SHPA shares PSA’s vision

HOSPITAL pharmacists welcomed the Pharmacists in 2030 report, launched by the Pharmaceutical Society of Australia (PSA) at PSA24.

The report supports pharmacy specialisation, collaborative care teams, and practitioner recognition, aligning with the Society of Hospital Pharmacists of Australia's (SHPA) own strategic vision.

SHPA President Tom Simpson said Pharmacists in 2030 serves as a complementary framework for SHPA's upcoming Statement on Advanced Pharmacy and strategic plan to guide the growing impact of the pharmacy profession on medicines safety and patient care.

"We absolutely recognise the need to update the definition of advanced practice in Australia," remarked Simpson.

The Pharmacists in 2030 recognises "urgent issues" facing the profession, while identifying actionable solutions, many of which echo the initiatives of SHPA's Transformation 2024 agenda, explained Simpson.

Additionally, PSA National President Fei Sim explained that the report "leverages the appetite for change in our health system", driven by patient needs, and provides a roadmap for the next six years on how pharmacists' full potential can be realised.

Sim added Pharmacists in 2030 "challenges the entire health ecosystem" to collaboratively drive pharmacy practice to the next level, including policymakers, patients, and consumers.

"We know that regulatory change alone is not enough," she said.

"We need to address the cultural and system factors which hold our profession back, and importantly, we cannot continue expecting pharmacists to do more with less." Pictured: Federal Health Minister Mark Butler and Sim at PSA24. JG